Cision PR Newswire

Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with...

- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 weeks, the...

Aker Carbon Capture proposes a cash dividend of NOK 3.5 billion

FORNEBU, Norway, Feb. 13, 2025 /PRNewswire/ -- Aker Carbon Capture ASA (ACC), an Aker Horizons portfolio company, today announced that the Board of Directors of...

NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcare

Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM. AUSTIN, Texas, Feb. 13, 2025...

Global Times: From tale of ‘Chang’e flying to the moon’ to legend of ‘Chang’e’ lunar exploration

BEIJING, Feb. 13, 2025 /PRNewswire/ -- The 15th day of the first month on the Chinese lunar calendar marks the Lantern Festival.The moon is full in...

VanceAI Launches AI Magic Upscaler: Redefining Image Enhancement with Generative AI Technology

HONG KONG, Feb. 12, 2025 /PRNewswire/ -- VanceAI, a provider of AI-powered photo enhancement, processing, and editing solutions, has released its new generative AI upscaling...